Lung Cancer Malpractice
EARLY DETECTION CRUCIAL
Early detection plays a crucial role in increasing the
rate of lung cancer survival. When people are diagnosed with early stage
lung cancer, their chances of five year survival can be as high as 85%.
But because symptoms may be vague or nonexistent in the early stages,
many people with lung cancer aren't diagnosed until the disease is in
late stage. Symptoms can include:
A recurring lung condition such as asthma, bronchitis
or pneumonia that does not clear up with prescribed medication; back
or shoulder pain;
Cough, Bloody sputum, Shortness of breath and orChest
Loss of appetite, Weight loss, Weakness, Fever
Swallowing difficulty, Hoarseness or changing voice
Joint or Bone pain
Facial swelling, Facial paralysis, Eyelid drooping
STAGES 1 THROUGH 4
Lung cancer is also broken down into four different stages.
This staging system provides a good understanding of the prognosis of
Stage 1 Disease: Stage 1 disease
is characterized by an absence of cancer spread to any lymph node whatsoever.
Stage 1A disease implies a very small cancer without lymph node involvement.
Stage 1B disease is a larger cancer without lymph node involvement.
Stage 2 Disease: Stage 2A and 2B
disease fundamentally refers to the presence of cancer in the hilar
lymph nodes, or N1 area, in addition to the primary site in the lung.
The presence of a tumor involving the chest wall without hilar lymph
node involvement (T3, N0) is also recognized as Stage 2B disease. These
tumors can be safely removed and surgically cured by cutting around
the malignant involvement in the chest wall, hence reverting the cancer
back to a Stage 2B instead of Stage 3.
Stage 3 Disease: Stage 3 disease
is broken down into two major categories: Stage 3A and Stage 3B disease.
Stage 3A disease involves the mediastinal lymph glands on the same side
as the cancer. This cancer may either be resectable initially or following
preoperative treatment. In patients with Stage 3B disease, there is
lymph node involvement on the other side of the chest, or in the supraclavicular
area (N3). These patients should never be considered for surgical resection.
Stage 4 Disease: Stage 4 disease
implies that the cancer has spread outside of the chest.
Lung Cancer News
Nov. 24, 2003
New Lung cancer drug that works -- for some
"Now researchers are racing to unravel why Iressa -- the first
significant new lung cancer drug in a generation -- appears to help
only select patients. They are studying the DNA of patients for clues,
hoping to develop a genetic screening test that would enable them to
get the drug to the right people quickly. If they succeed, a small portion
of lung cancer victims would get extra years of life. Given that 157,000
Americans die annually from the disease, the impact could be considerable...The
effort is part of an emerging area of medicine seeking to genetically
match patients to drugs."
Proper detection and diagnosis are critical for effective
treatment and survival. If you or a loved one have been the victim
of negligent or delayed lung cancer detection,
please contact us for help.